Skip to main content
SpringerLink
Log in

Desmoid tumour in familial adenomatous polyposis. A review of literature

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Desmoid tumours (DT) are rare benign tumours that do not metastasise, but tend to invade locally. DT are frequently seen in patients with familial adenomatous polyposis (FAP), and diagnosis and treatment are often difficult. Surgical trauma, genetic predisposition and hormonal factors are considered to be correlated with the development and growth of DT. In patients with FAP, 50% of the tumours are localised intra-abdominally, and 85–100% of these are mesenteric. DT frequently present as non-tender, slowly growing masses. The symptoms are abdominal pain, vomiting, diarrhoea or haematochezia. Mesenteric DT can cause small bowel obstruction or ischaemia, hydronephrosis or form fistulas. Diagnosis is obtained through biopsy and the extension is determined by a CT-scan. Surgical excision is recommended in patients with DT in the abdominal wall. First line treatment of mesenteric DT is a NSAID in combination with tamoxifen. Surgery may be considered in case of a small and well-defined DT with no signs of invasion of vital structures, and in cases of imminent bowel ischaemia or obstruction. The prognosis in mesenteric DT is serious, and improvement of the therapeutic strategy awaits current international studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lynch HT, Fitzgibbons R Jr. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 1996; 91: 2598-601.

    Google Scholar 

  2. Clark SK, Phillip RK. Desmoids in familial adenomatous polyposis. Br J Surg 1996; 83: 1494-504.

    Google Scholar 

  3. Clark SK, Neale KF, Landgrebe JC et al. Desmoid tumours complicating familial adenomatous polyposis. Br Jr Surg 1999; 86: 1185-9.

    Google Scholar 

  4. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP et al. Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994; 74: 1270-4.

    Google Scholar 

  5. Anthony T, Rodriguez-Bigas MA, Webwe TK et al. Desmoid tumor. J Am Col Surg 1996; 182: 369-77.

    Google Scholar 

  6. Järvinen HJ. Desmoid disease as a part of familial adenomatous polyposis coli. Acta Chir Scand 1997; 153: 379-83.

    Google Scholar 

  7. Gurbuz AK, Giardiello FM, Petersen GM et al. Desmoid tumors in familial adenomatous polyposis. Gut 1994; 35: 377-81.

    Google Scholar 

  8. Heiskanen I, Järvinen HJ. Occurence of desmoid tumours in familial adenomatous polyposis and result of treatment. Int J Colorectal Dis 1996; 11: 157-62.

    Google Scholar 

  9. Reitamo JJ, Pekka H, Nykri E. The desmoid tumour 1. Incidence, sex-, age-, and anatomic distribution in the Finnish population. Am J Clin Pathol 1986; 77: 665-73.

    Google Scholar 

  10. Reitamo JJ, Scheinin TM, Häyry P. The desmoid syndrome: new aspects in the cause, pathogenesis and treatment of the desmoid tumour. Am J Surg 1986; 151: 230-7.

    Google Scholar 

  11. Berk T, Cohen Z, McLeod RS et al. Management of mesenteric desmoid tumors in familial adenimatous polyposis. C J S. 1992; 35(4): 393-5.

    Google Scholar 

  12. Church JM, Mcgannon E, Ozuner G. The clinincal course of intra-abdominal desmoidtumors in patients with familial adenomatous polyposis. Colorectal Disease 1999; 1: 168-73.

    Google Scholar 

  13. Vasen HFA, Bülow S. The Leeds Castle Polyposis Group. Guidelines for the surveillance and management of familial adenomatous polyposis (FAP): a world wide survey among 41 registries. Colorectal Dis 1999; 1: 214-21.

    Google Scholar 

  14. Knudsen AL, Bülow S. Desmoid tumour in familial adenomatous polyposis. Ugeskr Laeg 2000; 162: 5628-31.

    Google Scholar 

  15. Bülow S. Familial polyposis coli. A clinical and epidemiological study. Thesis. Dan Med Bull 1986; 34: 1-15.

    Google Scholar 

  16. Bülow S. Incidence of associated diseases in familial Polyposis Coli. Semin Surg Onc 1987; 3: 84-7.

    Google Scholar 

  17. Cho KR, Vogelstein B. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem 1992; Suppl 16G: 137-41.

    Google Scholar 

  18. Nilbert M, Fernebro J, Kristoffersen U. Novel germline APC mutations in swedish patients with familial adenomatous polyposis and Gardner syndrome. Scand J Gastroenterol 2000; 35: 1200-3.

    Google Scholar 

  19. Giarola M, Stagi L, Presciuttini S et al. Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat 1999; 13: 116-23.

    Google Scholar 

  20. Sen-Gupta S, Van der Luijt RB, Bowles LV et al. Somatic mutation of APC-gene in desmoid tumour in familial adenomatous polyposis. Lancet 1993; 342: 552-3.

    Google Scholar 

  21. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.

    Google Scholar 

  22. Scates DK, Clark SK, Phillips RKS et al. Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis. Br Jr Surg 1998; 85: 965-9.

    Google Scholar 

  23. Middleton SB, Pack K, Phillips RKS. Telomere length in familial adenomatous polyposis-associated desmoids. Dis Colon Rectum 2000; 43: 1535-9.

    Google Scholar 

  24. Middleton SB, Frayling IM, Phillips RKS. Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br Jr Cancer 2000; 84(4): 827-32.

    Google Scholar 

  25. De Wever I, Cin PD, Fletcher CDM et al. Cytogenetic, clinical and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. Mod Pathol 2000; 13(10): 1080-5.

    Google Scholar 

  26. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al. Coexistence of somatic and germline mutations of APC-gene in desmoid tumours from patients with familial adenomatous polyposis. Cancer Res 1993; 53: 5079-82.

    Google Scholar 

  27. Dangel A, Meloni AM, Lynch HT et al. Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome. Cancer Genet Cytogenet 1994; 78: 94-8.

    Google Scholar 

  28. Yoshida MA, Ikeuchi T, Iwama T et al. Chromosome changes in desmoid tumours developed in patients with familial adenomatous polyposis. Jpn J Cancer Res 1991; 82: 916-21.

    Google Scholar 

  29. de Silva DC, Wright MF, Stevenson DAJ et al. Cranial desmoid tumor associated with homozygous inactivation of the adenomnatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis. Cancer 1996; 77: 972-6.

    Google Scholar 

  30. Lamlum H, Ilyas M, Rowan A et al. The type of somatic mutation aat APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's ‘two-hit’ hypothesis. Nature Medicine 1999; 5(9): 1071-5.

    Google Scholar 

  31. Enomoto M, Konishi M, Iwama T et al. The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. Jpn J Clin Oncol 2000; 30(2): 82-8.

    Google Scholar 

  32. Palmirotta R, Curia MC, Esposito DL. Novel mutations and inactivation of both alleles of the APCgene in desmoid tumours. Hum Mol Genet 1995; 4: 1979-81.

    Google Scholar 

  33. Caspari R, Olschwang S, Friedl W et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4: 337-40.

    Google Scholar 

  34. Couture J, Mitri A, Lagace R et al. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumour. Clin Genet 2000; 57: 205-12.

    Google Scholar 

  35. Clark SK, Johnson Smith TGP, Katz DE et al. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br Jr Surg 1998; 85: 970-3.

    Google Scholar 

  36. Serpell JW, Paddle-Ledinek JE, Johnson WR. Modification of growth of desmoid tumours in tissue culture by antiestrogenic substances: a preliminary report. Aust N Z J Surg 1996; 66: 457-63.

    Google Scholar 

  37. Avisse C, Elbaz M, Pluot M et al. Desmoid tumor of the abdominal wall: report of seven cases. Hernia 1997; 1: 163-7.

    Google Scholar 

  38. Soravia C, Berk T, McLeod RS et al. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 363-9.

    Google Scholar 

  39. Penna C, Tiret E, Parc R et al. Operation and abdominal desmoid-tumours in familial adenomatous polyposis. SGO 1993; 177: 263-8.

    Google Scholar 

  40. Sagar PM, Möslein G, Dozois RR et al. Management of desmoid tumours in patients after ileal pouch-anal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1998; 41: 1350-6.

    Google Scholar 

  41. Häyry P, Reitamo JJ, Totterman S et al. The desmoid tumour 2. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 1982; 77: 674-80.

    Google Scholar 

  42. Church JM, McGannon E. Prior pregnancy ameliorates the course of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 445-50.

    Google Scholar 

  43. Lynch HT, Fitzgibbons R Jr, Chong S et al. Use of doxorubicin and dacarbazine for the management of unresectable intraabdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 1994; 37: 260-7.

    Google Scholar 

  44. Bataini JP, Belloir C, Mazabraud A et al. Desmoid tumours in adults: the role of radiotherapy in their management. Am J Surg 1988; 155: 754-60.

    Google Scholar 

  45. Waddell WR, Kirsch WM. Testolactone, sulindac, warfarin and vitamin K1 for unresectable desmoid tumours. Am J Surg 1991; 161: 416-21.

    Google Scholar 

  46. Lev-Chelouche D, Abu-Abeid S, Nakache R et al. Limb desmoid tumours: a possible role for isolated limb perfusion with tumour necrosis factor-alpha ang melphalan. Surgery 1999; 126: 963-7.

    Google Scholar 

  47. Soule EH, Scanlon PW. Fibrosarcoma arising in an extra-abdominal desmoid. Mayo Clin Proc 1962; 37: 433.

    Google Scholar 

  48. Lambroza A, Tighe MK, DeCosse JJ et al. Disorders of the rectus abdominis muscle and sheath: a 22-year experience. Am J Gastroenterol 1995; 90(8): 1313-7.

    Google Scholar 

  49. Church JM. Mucosal ischaemia caused by desmoid tumors in patients with familial adenomatous polyposis. Dis Colon Rectum 1998; 41: 661-3.

    Google Scholar 

  50. Maldjian C, Mitty H, Garten A et al. Abscess formation in a desmoid tumor of Gardner's syndrome and percutaneous drainage: a report of three cases. Cardiovasc Intervent Radiol 1995; 18: 168-71.

    Google Scholar 

  51. Richard III HM, Thall EH, Mitty H et al. Desmoid tumor-ureteral fistula in Gardner's syndrome. Urology 1997; 49: 135-8.

    Google Scholar 

  52. Doi K, Iida M, Kohrogi N. Large intra-abdominal desmoid tumours in a patient with familial adenomatous coli: their rapid growth detected by computerized tomography. Am J Gastroenterol 1993; 88(4): 595-8.

    Google Scholar 

  53. Healy JC, Reznek RH, Clark SK et al. MR appearances of desmoid tumours in familial adenomatous polyposis. Am J Roentgenol 1997; 169: 465-72.

    Google Scholar 

  54. Brooks AP, Reznek RH, Nugent K et al. CT appearances of desmoid tumors in familial adenomatous polyposis; further observations. Clin Radiol 1994; 49: 601-7.

    Google Scholar 

  55. Vandevenne JE, De Schepper AM, De Beuckeleer et al. New concepts in understanding evolution of desmoid tumoures: MR imaging of 30 lesions. Eur Radiol 1997; 7: 1013-9.

    Google Scholar 

  56. Mariani A, Nascimento AG, Webb MJ et al. Surgical management of desmoid tumors of the female pelvis. J Am Coll Surg 2000; 191: 175-83.

    Google Scholar 

  57. Reitamo JJ. The desmoid tumour 4. Choice of treatment, results and complications. Arch Surg 1983; 118: 1318-22.

    Google Scholar 

  58. Rock MG, Pritchard DJ, Reiman HM, et al. Extra-abdominal desmoid tumors. J Bone Joint Surg 1984; 66: 1369-74.

    Google Scholar 

  59. Middleton SB, Phillips RKS. Surgery for large intra-abdominal desmoid tumours. Dis Colon Rectum 2000; 43: 1759-63.

    Google Scholar 

  60. Tonelli F, Valanzano R, Brandi ML. Pharmacologic treatment of demoid tumours in familial adenomatous polyposis: results of an in vitro study. Surgery 1994; 115: 473-9.

    Google Scholar 

  61. Picariello L, Brandi ML, Formigli L et al. Apoptosis by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. Eur J Pharmacol 1998; 360: 105-12.

    Google Scholar 

  62. Tsukada K, Church JM, Jagelman DG, et al. Noncytotoxic drug therapy for intraabdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 1992; 35: 29-33.

    Google Scholar 

  63. Samuels BL. Management of recurrent desmoid tumor after surgery and radiation: role of cytotoxic and non-cytotoxic therapies. Surg Oncol 1999; 8: 191-6.

    Google Scholar 

  64. Klein WA, Miller HH, Anderson M et al. The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer 1987; 60: 2863-8.

    Google Scholar 

  65. Lim CL, Walker MJ, Mehta RR et al. Oestrogen and anti-oestrogen binding sites in desmoid tumors. Eur J Cancer Clin 1986; 22: 583-7.

    Google Scholar 

  66. Häyry P, Reitamo JJ, Totterman S et al. The desmoid tumour 3. A biochemical and genetical analysis. Am J Clin Pathol 1982; 77: 681-5.

    Google Scholar 

  67. Picariello L, Fiorelli G, Benvenuti S et al. In vitro bioeffects of the antiestrogen LY117018 on desmoidtumour and colon cancer cells. Anticancer Res 1997; 17: 2099-104.

    Google Scholar 

  68. Hamilton L, Blackstein M, Berk T et al. Chemotherapy for desmoidtumors in association with familial adenomatous polyposis: a report af three cases. Can J Surg 1996 39: 247-52.

    Google Scholar 

  69. Schnitzler M, Cohen Z, Blackstein M et al. Chemotherapy for desmoidtumors in association with familial adenomatous polyposis. Dis Colon Rectum 1997; 40: 798-801.

    Google Scholar 

  70. Tsukada K, Church JM, Jagelman DG et al. Systemic cytotoxic chemotherapy for desmoid in familial adenomatous polyposis. Dis Colon Rectum 1991; 34: 1090-2.

    Google Scholar 

  71. Kitamura A, Kanagawa T, Yamada S et al. Effective chemotherapy for abdominal desmoid tumour in a patient with Gardner's syndrome. Dis Colon Rectum 1991; 34: 822-6.

    Google Scholar 

  72. Oohata Y, Mibu R, Uehara S et al. Regression of an abdominal desmoid tumour in a patient with familial adenomatous polyposis by hyperthermoradiotherapy. Am J Gastroenterol 1997; 92(1): 156-8.

    Google Scholar 

  73. Nakada I, Ubukata H, Goto Y et al. Prednisolone therapy for intraabdominal desmoid tumours in a patient with familial adenomatous polyposis. Gastroenterol 1997; 32: 255-9.

    Google Scholar 

  74. Geurs F, Kok TC. Regression of a great abdominal desmoid tumor by interferon-alpha. J Clin Gastroenterol 1993; 16(3): 264-5.

    Google Scholar 

  75. Umemoto S, Makuuchi H, Amemiya T et al. Intra-abdominal desmoid tumours in familial polyposis coli: a case report of tumour regression by prednisolone therapy. Dis Colon Rectum 1991; 34: 89-93.

    Google Scholar 

  76. Wilcken N, Tattersall MHN. Endocrine therapy for desmoid tumors. Cancer 1991; 68: 1384-8.

    Google Scholar 

  77. Stojadinovic A, Hoos A, Karpoff HM et al. Soft tissue tumours of the abdominal wall. Arch Surg 2001; 136: 70-9.

    Google Scholar 

  78. Ballo MT, Zagars GK, Pollack A et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999; 17: 158-67.

    Google Scholar 

  79. Bertario L, Presciuttini S, Sala P et al. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry of Familial Adenomatous Polyposis Writing Committee. Semin Surg Oncol 1994; 10: 225-34.

    Google Scholar 

  80. Belchetz LA, Berk T, Bapat BV et al. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996; 39: 384-7.

    Google Scholar 

  81. Northover JMA. Activities of the Leeds Castle Polyposis Group. Semin Surg Oncol 1987; 3: 118-9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Danish Polyposis Register, Department of Surgical Gastroenterology, Hvidovre University Hospital, Hvidovre, Denmark

    Anne Lyster Knudsen

  2. The Danish Polyposis Register, Department of Surgical Gastroenterology, Hvidovre University Hospital, DK-2650, Hvidovre, Copenhagen, Denmark

    Steffen Bülow

Authors
  1. Anne Lyster Knudsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steffen Bülow
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knudsen, A.L., Bülow, S. Desmoid tumour in familial adenomatous polyposis. A review of literature. Familial Cancer 1, 113–121 (2001). https://doi.org/10.1023/A:1013841813544

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013841813544

Search

Navigation